Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brody

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2021
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic reviewAdam S Komorowski, Anthony D Bai, Anna Cvetkovic, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Bispecific antibody targeting of lipid nanoparticlesAngelo Amabile, Matthew Phelan, Zhixin Yu, et al.
Translational Oncology|January 5, 2021
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformationBrendan P Hodkinson, Michael Schaffer, Joshua D Brody, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Brain-wide coordination of decision formation and commitmentAdrian G Bondy, Julie A Charlton, Thomas Zhihao Luo, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2021
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?Adam S Komorowski, Anthony D Bai, Anna Cvetkovic, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-primingMark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
Nature Medicine|April 10, 2019
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationLinda Hammerich, Thomas U Marron, Ranjan Upadhyay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyJoshua D Brody, Weiyun Z Ai, Debra K Czerwinski, et al.
Nature Communications|November 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunityJudit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, et al.
Nature Biotechnology|April 29, 2026
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expressionAdam Marks, Sophia Siu, Filippo Bianchini, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 11, 2021
Methodological and reporting quality of non-inferiority randomized controlled trials comparing antifungal therapies: a systematic reviewAdam S Komorowski, Anthony D Bai, Anna Cvetkovic, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Bispecific antibody targeting of lipid nanoparticlesAngelo Amabile, Matthew Phelan, Zhixin Yu, et al.
Translational Oncology|January 5, 2021
Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformationBrendan P Hodkinson, Michael Schaffer, Joshua D Brody, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Brain-wide coordination of decision formation and commitmentAdrian G Bondy, Julie A Charlton, Thomas Zhihao Luo, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2021
Secondary Analysis of a Systematic Review: Are Antifungal Noninferiority Trials at Risk of Eroding Effectiveness Because of Biocreep?Adam S Komorowski, Anthony D Bai, Anna Cvetkovic, et al.
Journal for Immunotherapy of Cancer|July 24, 2023
Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-primingMark Aleynick, Judit Svensson-Arvelund, Gvantsa Pantsulaia, et al.
Nature Medicine|April 10, 2019
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationLinda Hammerich, Thomas U Marron, Ranjan Upadhyay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II studyJoshua D Brody, Weiyun Z Ai, Debra K Czerwinski, et al.
Nature Communications|November 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunityJudit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, et al.
Nature Biotechnology|April 29, 2026
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expressionAdam Marks, Sophia Siu, Filippo Bianchini, et al.
Pageof 24